Collegium Pharmaceutical, Inc (COLL) stock
COLLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/3045% below fair value
$24.81+0.34 (+1.39%)
Close on Nov 11, 2026Market cap $807.71MP/E 24.8Yield –
Collegium Pharmaceutical profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Collegium Pharmaceutical's profit margin for the twelve months ending Sep 30, 2026 was 4.7%. For fiscal 2025 it was 8.1%, against 11.0% the year before. The highest annual figure on record is 25.8% in fiscal 2021.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8.1% | −2.9 |
| FY2024 | Dec 31, 2024 | 11.0% | +2.5 |
| FY2023 | Dec 31, 2023 | 8.5% | +13.9 |
| FY2022 | Dec 31, 2022 | -5.4% | −31.2 |
| FY2021 | Dec 31, 2021 | 25.8% | +17.2 |
| FY2020 | Dec 31, 2020 | 8.6% | +16.3 |
| FY2019 | Dec 31, 2019 | -7.7% | +6.3 |
| FY2018 | Dec 31, 2018 | -14.0% | +249.0 |
| FY2017 | Dec 31, 2017 | -262.9% | +5241.2 |
| FY2016 | Dec 31, 2016 | -5504.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 10.1% | −5.0 |
| Q2 FY2026 | Jun 30, 2026 | -7.5% | −13.9 |
| Q1 FY2026 | Mar 31, 2026 | 7.5% | +6.1 |
| Q4 FY2025 | Dec 31, 2025 | 8.3% | +1.4 |
| Q3 FY2025 | Sep 30, 2025 | 15.0% | +9.2 |
| Q2 FY2025 | Jun 30, 2025 | 6.4% | −7.1 |
| Q1 FY2025 | Mar 31, 2025 | 1.4% | −17.8 |
| Q4 FY2024 | Dec 31, 2024 | 6.9% | −14.4 |
| Q3 FY2024 | Sep 30, 2024 | 5.9% | −9.2 |
| Q2 FY2024 | Jun 30, 2024 | 13.5% | +3.9 |
| Q1 FY2024 | Mar 31, 2024 | 19.1% | +31.2 |
| Q4 FY2023 | Dec 31, 2023 | 21.3% | +26.9 |
| Q3 FY2023 | Sep 30, 2023 | 15.1% | +14.7 |
| Q2 FY2023 | Jun 30, 2023 | 9.6% | +13.8 |
| Q1 FY2023 | Mar 31, 2023 | -12.0% | +3.6 |
| Q4 FY2022 | Dec 31, 2022 | -5.6% | +85.9 |
| Q3 FY2022 | Sep 30, 2022 | 0.4% | −9.8 |
| Q2 FY2022 | Jun 30, 2022 | -4.2% | −92.0 |
| Q1 FY2022 | Mar 31, 2022 | -15.6% | −33.5 |
| Q4 FY2021 | Dec 31, 2021 | -91.5% | −100.6 |
| Q3 FY2021 | Sep 30, 2021 | 10.2% | −4.0 |
| Q2 FY2021 | Jun 30, 2021 | 87.8% | +77.5 |
| Q1 FY2021 | Mar 31, 2021 | 17.9% | +17.3 |
| Q4 FY2020 | Dec 31, 2020 | 9.1% | +12.1 |
| Q3 FY2020 | Sep 30, 2020 | 14.3% | +22.6 |
| Q2 FY2020 | Jun 30, 2020 | 10.3% | +16.6 |
| Q1 FY2020 | Mar 31, 2020 | 0.6% | +13.6 |
| Q4 FY2019 | Dec 31, 2019 | -3.0% | −15.3 |
| Q3 FY2019 | Sep 30, 2019 | -8.4% | +15.1 |
| Q2 FY2019 | Jun 30, 2019 | -6.3% | +11.6 |
| Q1 FY2019 | Mar 31, 2019 | -13.0% | +16.2 |
| Q4 FY2018 | Dec 31, 2018 | 12.4% | +173.6 |
| Q3 FY2018 | Sep 30, 2018 | -23.5% | +87.5 |
| Q2 FY2018 | Jun 30, 2018 | -17.9% | +575.4 |
| Q1 FY2018 | Mar 31, 2018 | -29.3% | +1033.3 |
| Q4 FY2017 | Dec 31, 2017 | -161.2% | +1953.8 |
| Q3 FY2017 | Sep 30, 2017 | -111.0% | – |
| Q2 FY2017 | Jun 30, 2017 | -593.3% | – |
| Q1 FY2017 | Mar 31, 2017 | -1062.5% | – |
| Q4 FY2016 | Dec 31, 2016 | -2115.0% | – |
See a number that looks wrong?